Serologic screening for viral infections among blood donors: a study in a blood bank in southern Brazil
- PMID: 39230147
- PMCID: PMC11370740
- DOI: 10.1590/1806-9282.20240452
Serologic screening for viral infections among blood donors: a study in a blood bank in southern Brazil
Abstract
Background: Routine screening for viral infections at blood donation is important to avoid transfusion-transmitted infections. It also offers an opportunity to detect an asymptomatic infection.
Objective: To study changes in serology positivity for viral infections (B and C hepatitis, HTLV-1/2, and HIV) at blood donation in a blood bank from Southern Brazil, comparing two periods of 5 years: the period from 2013 to 2017 with the period from 2018 to 2022. In addition, data on the donor fidelity rate during the studied period were sought.
Methods: Retrospective study using data from 2013 to 2022 from a single blood center electronic database from Curitiba, Southern Brazil.
Results: A significant drop in positive serology for all studied viruses was observed: highest in HIV (OR=0.39; 95% CI=0.27-0.57) and lowest in total anti HBc (0.56; 95 CI=0.50-0.63). Anti HBc serology became more commonly seen in women in the period of 2018-2022 when compared to men. No changes in the distribution of positive serology according to donors' ages were observed. Loyalty rates had a median of 70%, with the lowest being 60% in 2013, while the highest was 73% in 2018 and 2022.
Conclusion: A significant reduction in discarded blood bags due to viral serology was observed when the period of 2013-2017 was compared to 2018-2022 on this blood bank; the highest reduction was observed in HIV serology and the lowest in HBc serology, which became more common in women in the second period. High rates of donor fidelity were observed during the period studied.
Conflict of interest statement
Figures
Similar articles
-
Blood discard rate in a blood center in Curitiba - Brazil. Ten years of study.Transfus Apher Sci. 2017 Apr;56(2):130-134. doi: 10.1016/j.transci.2016.10.007. Epub 2016 Oct 25. Transfus Apher Sci. 2017. PMID: 28029567
-
[Safe blood in the absence of viral infections due to HBV, HCV and HIV in serological window period in donors].Salud Publica Mex. 2011;53 Suppl 1:S13-8. Salud Publica Mex. 2011. PMID: 21877067 Spanish.
-
Positive serology for viral hepatitis and donor self-exclusion in Southern Brazil.Rev Soc Bras Med Trop. 2013 Jul-Aug;46(4):403-10. doi: 10.1590/0037-8682-0094-2013. Rev Soc Bras Med Trop. 2013. PMID: 23982095
-
[Detection of the nucleic acids of hepatitis B and C viruses and human immunodeficiency virus for the biological screening of blood donations. Viral Hepatitis and Retrovirus Working Groups and Subgroup for Molecular Biology Applied to Transfusion Virology of the French Blood Transfusion Society].Transfus Clin Biol. 1998 Apr;5(2):139-46. doi: 10.1016/s1246-7820(98)80004-9. Transfus Clin Biol. 1998. PMID: 9618839 Review. French.
-
HIV, HBV and HCV: new developments related to transfusion safety.Vox Sang. 2000;78 Suppl 2:253-6. Vox Sang. 2000. PMID: 10938963 Review. No abstract available.
Cited by
-
Comment on: "Serologic screening for viral infections among blood donors: a study in a blood bank in southern Brazil".Rev Assoc Med Bras (1992). 2025 Jul 7;71(6):e20250246. doi: 10.1590/1806-9282.20250246. eCollection 2025. Rev Assoc Med Bras (1992). 2025. PMID: 40638479 Free PMC article. No abstract available.
References
-
- Ministério da Saúde, Secretaria de Vigilância em Saúde Boletim epidemiológico de hepatites virais 2021 - Edição Especial. 2021. Available from: https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/boletins... .
-
- Pereira GH, Peixoto HR, Giusti ML, Souza ML, Victor LB, Fernandes F, et al. Long-term survival and clinical outcomes following direct-acting antiviral (DAA) treatment in HCV decompensated cirrhosis in Brazil: a real-world study. Braz J Infect Dis. 2022;26(5):102697–102697. doi: 10.1016/j.bjid.2022.102697. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical